Haematology and Oncology

Trials and guidelines in haematology and oncology
Interpretation of Haematology Tests
Morphological abnormalities of red blood cells
RBC inclusions: Heinz bodies and Howell-Jolly bodies
Leukemoid reaction
Leukocyte abnormalities on blood film inspection
Plasmacytosis and smudge cell lymphocytes
Interpretation of iron studies
Viscoelastic tests of clotting function (TEG and ROTEM)
Interpretation of abnormal coagulation studies
Intepretation of abnormal ROTEM data
Coagulopathy and Anticoagulation
Heparin resistance
A brief summary of antiplatelet agents
A brief summary of oral anticoagulant agents
Reversal of Anticoagulation and Correction of Coagulopathy
Recombinant Factor VII (NovoSeven)
Tranexamic acid and aminocaproic acid
Desmopressin (DDAVP) in the treatment of platelet dysfunction
Reversal agents for anticoagulants
Pharmacological haemostatic agents in cardiothoracic surgery
Scenarios in Critical Care Haematology
Haemolytic anaemia
Tumour lysis syndrome
Management of the post-splenectomy patient
Massive splenomegaly
Sickle cell crisis
Veno-occlusive disease of the bone marrow transplant recipient
Graft versus host disease
Haemophagocytic lymphohistiocytosis
Disorders of Haemopoiesis
Anaemia in critical care
Thrombocytopenia
Pancytopenia
Administration of Blood Products
Blood transfusion in the ICU
ABO blood grouping and transfusion compatibility
Massive blood product transfusion
Storage lesions of banked red blood cells
Irradiated blood products
Leukodepleted blood products
Transfusion reactions
Disorders of Thrombosis
The "Thrombophilic Screen"
Deep venous thrombosis in critical care
Thromboprophylaxis for the critically ill patient
Vena cava filters
Thrombotic thrombocytopenic purpura
Catastrophic antiphospholipid syndrome
Heparin-Induced Thrombocytopenia
Von Willebrand disease
Disseminated intravascular coagulation (DIC)
Vaccine-induced immune thrombotic thrombocytopenia (VITT)

[Submit a comment or correction]